Dose escalation trials are a critical phase in clinical research for cancer treatments. These trials aim to determine the maximum tolerated dose (MTD) of a new drug or therapy. By systematically increasing the dose given to patient cohorts, researchers seek to identify the point at which a drug begins to produce unacceptable side effects while maintaining its therapeutic efficacy.
